Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus?

作者: Abdulzahra Hussain , Hind Mahmood , EL-Hasani Shamsi , None

DOI:

关键词: Gastric bypass surgeryMedicinePancreas transplantationGlucose homeostasisHyperinsulinemiaType 1 diabetesDiabetes mellitusTransplantationSurgeryInternal medicineType 2 diabetes

摘要: Diabetes mellitus is the most common endocrine disorder, currently affecting more than 170 million people worldwide and prospectively 365 in year 2030.1 Surgical treatment of diabetes form pancreatic transplantation has emerged as single effective means achieving normal glucose homeostasis this patient population.2 Since first successful pancreas performed 1966, there been considerable progress field,3 notable being combined pancreas–kidney transplantation, which was reported 1967.4 The shortage organs available for rejection adverse effects associated with immune suppression have shown to limit wide clinical application treat patients diabetes. Thus, type 1 no choice but continue insulin therapy. Although recent advances islets success Edmonton group (a small series 7 patients) are encouraging diabetic patients, complexity technique problems could its benefit.5,6 Similarly, 2 successfully controlled gastric bypass surgery morbidly obese patients; considered be breakthrough surgical diabetes. Several classes antidiabetic agents, including analogs (e.g., glucagon-like peptide-1 [GLP-1] receptor agonists such exenatide) use either monotherapies or combination improve glycemic control diabetes.7 However, failure these medications address all pathophysiological defects frequently during course disease. Friedman colleagues8 1955 evidence that (subtotal gastrectomy) improved conditions patients. This finding received little attention until almost 30 years later. One study published 1982 suggested massive weight loss after accompanied by an improvement number, basal hyperinsulinemia tolerance.9 In 1984, Hughes colleagues10 concluded studying 6 control. Furthermore, a report 1992 severely bypass.11 Many subsequent studies high controlling rates ranging from 76.5% 97.0%.12 randomized trials needed verify effectiveness on nonobese diabetes, potential change current concepts pathophysiology and, possibly, management disease.13 very support further needed. Based prevalence fact promising option, we sought explore theoretical applicability

参考文章(64)
Friedman Mn, Magovern Gj, Sancetta Aj, The amelioration of diabetes mellitus following subtotal gastrectomy. Surgery gynecology & obstetrics. ,vol. 100, pp. 201- ,(1955)
DG McLarty, I Athaide, GF Bottazzo, AMB Swai, KGMM Alberti, None, Islet cell antibodies are not specifically associated with insulin-dependent diabetes in Tanzanian Africans. Diabetes Research and Clinical Practice. ,vol. 9, pp. 219- 224 ,(1990) , 10.1016/0168-8227(90)90048-X
Alberto Patriti, Maria Cristina Aisa, Claudia Annetti, Angelo Sidoni, Francesco Galli, Ivana Ferri, Nino Gullà, Annibale Donini, How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number. Surgery. ,vol. 142, pp. 74- 85 ,(2007) , 10.1016/J.SURG.2007.03.001
Hiroyuki Mori, Takashi Shichita, Qingsheng Yu, Ryoko Yoshida, Masayuki Hashimoto, Fuyuki Okamoto, Takahiro Torisu, Mako Nakaya, Takashi Kobayashi, Giichi Takaesu, Akihiko Yoshimura, Suppression of SOCS3 expression in the pancreatic β-cell leads to resistance to type 1 diabetes Biochemical and Biophysical Research Communications. ,vol. 359, pp. 952- 958 ,(2007) , 10.1016/J.BBRC.2007.05.198
WALTER J. PORIES, KENNETH G. MACDONALD, EDWARD G. FLICKINGER, G. LYNIS DOHM, MADHUR K. SINHA, HISHAM A. BARAKAT, HAROLD J. MAY, PRABHAKER KHAZANIE, MELVIN S. SWANSON, ELIZABETH MORGAN, NANCY LEGGETT-FRAZIER, STUART D. LONG, BRENDA M. BROWN, KEVIN OʼBRIEN, JOSE F. CARD, Is type II diabetes mellitus (NIDDM) a surgical disease Annals of Surgery. ,vol. 215, pp. 633- 643 ,(1992) , 10.1097/00000658-199206000-00010
L. Czupryniak, J. Strzelczyk, K. Cypryk, M. Pawlowski, D. Szymanski, A. Lewinski, J. Loba, Gastric bypass surgery in severely obese type 1 diabetic patients Diabetes Care. ,vol. 27, pp. 2561- 2562 ,(2004) , 10.2337/DIACARE.27.10.2561
Jay S. Skyler, Diabetes mellitus: Pathogenesis and treatment strategies Journal of Medicinal Chemistry. ,vol. 47, pp. 4113- 4117 ,(2004) , 10.1021/JM0306273
Andrew A. Gumbs, Irvin M. Modlin, Garth H. Ballantyne, Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obesity Surgery. ,vol. 15, pp. 462- 473 ,(2005) , 10.1381/0960892053723367
M. Suter, A. Paroz, J.-M. Calmes, V. Giusti, European experience with laparoscopic Roux-en-Y gastric bypass in 466 obese patients. British Journal of Surgery. ,vol. 93, pp. 726- 732 ,(2006) , 10.1002/BJS.5336
David Pacheco, Daniel Antonio de Luis, Alejandro Romero, Manuel González Sagrado, Rosa Conde, Olatz Izaola, Rocío Aller, Alberto Delgado, The Effects of Duodenal-Jejunal Exclusion on Hormonal Regulation of Glucose Metabolism in Goto-Kakizaki Rats American Journal of Surgery. ,vol. 194, pp. 221- 224 ,(2007) , 10.1016/J.AMJSURG.2006.11.015